IRON BINDING CAPACITY TOTAL DECREASED

This adverse event was reported 221 times

These drugs are most commonly taken by patients reporting IRON BINDING CAPACITY TOTAL DECREASED:

# Drug Count
See all common drugs associated with IRON BINDING CAPACITY TOTAL DECREASED

IRON BINDING CAPACITY TOTAL DECREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
See all drugs enriched for association with IRON BINDING CAPACITY TOTAL DECREASED

IRON BINDING CAPACITY TOTAL DECREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Serotonin-4 Receptor Agonist [EPC] 1 0.0015
1 Interleukin-5 Antagonist [EPC] 1 0.0015
2 CD19-directed Cytolytic Antibody [EPC] 1 0.0012
3 Paramagnetic Contrast Agent [EPC] 3 0.0007
4 Provitamin D2 Compound [EPC] 19 0.0006
5 Complement Inhibitor [EPC] 30 0.0005
6 Guanylate Cyclase-C Agonist [EPC] 1 0.0005
7 Vitamin D3 Analog [EPC] 6 0.0003
8 Vitamin D2 Analog [EPC] 2 0.0003
9 Iron Chelator [EPC] 8 0.0003
See all drug classes enriched for association with IRON BINDING CAPACITY TOTAL DECREASED